|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forner A, Reig M and Bruix J:
Hepatocellular carcinoma. Lancet. 391:1301–1314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Makarova-Rusher OV, Altekruse SF, McNeel
TS, Ulahannan S, Duffy AG, Graubard BI, Greten TF and McGlynn KA:
Population attributable fractions of risk factors for
hepatocellular carcinoma in the United States. Cancer.
122:1757–1765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jain D, Nayak NC, Kumaran V and Saigal S:
Steatohepatitic hepatocellular carcinoma, a morphologic indicator
of associated metabolic risk factors: A study from India. Arch
Pathol Lab Med. 137:961–966. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hartke J, Johnson M and Ghabril M: The
diagnosis and treatment of hepatocellular carcinoma. Semin Diagn
Pathol. 34:153–159. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Portolani N, Coniglio A, Ghidoni S,
Giovanelli M, Benetti A, Tiberio GA and Giulini SM: Early and late
recurrence after liver resection for hepatocellular carcinoma:
Prognostic and therapeutic implications. Ann Surg. 243:229–235.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moran VA, Perera RJ and Khalil AM:
Emerging functional and mechanistic paradigms of mammalian long
non-coding RNAs. Nucleic Acids Res. 40:6391–6400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Z, Wang S, Yang F, Meng Z and Liu Y:
LncRNA ROR1-AS1 high expression and its prognostic significance in
liver cancer. Oncol Rep. 43:55–74. 2020.PubMed/NCBI
|
|
10
|
Xu J, Lu Y, Liu Q, Xia A, Zhao J, Xu X,
Sun Q, Qi F and Sun B: Long noncoding RNA GMAN promotes
hepatocellular carcinoma progression by interacting with eIF4B.
Cancer Lett. 473:1–12. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo Y, Lin J, Zhang Y, Dai G, Li A and Liu
X: LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma
and promotes proliferation through the regulation of cell cycle
arrest and apoptosis. Cell Biochem Funct. 38:895–904. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu J, Ou Z, Lei Y, Chen L, Su Q and Zhang
K: LncRNA MYCNOS facilitates proliferation and invasion in
hepatocellular carcinoma by regulating miR-340. Hum Cell.
33:148–158. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Ding X, Xiu S, Du G and Liu Y:
LncRNA NEAT1 promotes proliferation, migration and invasion via
regulating miR-296-5p/CNN2 axis in hepatocellular carcinoma cells.
Onco Targets Ther. 12:9887–9897. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang W, Huang F, Lei Z and Luo H: LncRNA
SNHG11 promotes proliferation, migration, apoptosis, and autophagy
by regulating hsa-miR-184/AGO2 in HCC. Onco Targets Ther.
13:413–421. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pu J, Wang J, Wei H, Lu T, Wu X, Wu Y,
Shao Z, Luo C and Lu Y: lncRNA MAGI2-AS3 prevents the development
of HCC via recruiting KDM1A and promoting H3K4me2 demethylation of
the RACGAP1 promoter. Mol Ther Nucleic Acids. 18:351–362. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou Y, Huan L, Wu Y, Bao C, Chen B, Wang
L, Huang S, Liang L and He X: LncRNA ID2-AS1 suppresses tumor
metastasis by activating the HDAC8/ID2 pathway in hepatocellular
carcinoma. Cancer Lett. 469:399–409. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bo C, Li X, He L, Zhang S, Li N and An Y:
A novel long noncoding RNA HHIP-AS1 suppresses hepatocellular
carcinoma progression through stabilizing HHIP mRNA. Biochem
Biophys Res Commun. 520:333–340. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui H, Zhang Y, Zhang Q, Chen W, Zhao H
and Liang J: A comprehensive genome-wide analysis of long noncoding
RNA expression profile in hepatocellular carcinoma. Cancer Med.
6:2932–2941. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao QJ, Zhang J, Xu L and Liu FF:
Identification of a five-long non-coding RNA signature to improve
the prognosis prediction for patients with hepatocellular
carcinoma. World J Gastroenterol. 24:3426–3439. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng B, Yang M, Wang M and Liu Z:
Development and validation of 9-long non-coding RNA signature to
predicting survival in hepatocellular carcinoma. Medicine
(Baltimore). 99:e204222020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Greene FL: The American joint committee on
cancer: Updating the strategies in cancer staging. Bull Am Coll
Surg. 87:13–15. 2002.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Howley BV and Howe PH: TGF-beta signaling
in cancer: Post-transcriptional regulation of EMT via hnRNP E1.
Cytokine. 118:19–26. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
E C, Yang J, Li H and Li C: LncRNA
LOC105372579 promotes proliferation and epithelial-mesenchymal
transition in hepatocellular carcinoma via activating
miR-4316/FOXP4 signaling. Cancer Manag Res. 11:2871–2879. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo D, Li Y, Chen Y, Zhang D, Wang X, Lu
G, Ren M, Lu X and He S: DANCR promotes HCC progression and
regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1
pathway. Cell Prolif. 52:e126282019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang
C, Dou C, Xu M, Liu Q and Tu K: Long non-coding RNA CASC2
suppresses epithelial-mesenchymal transition of hepatocellular
carcinoma cells through CASC2/miR-367/FBXW7 axis. Mol Cancer.
16:1232017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu L, Yang N, Du G, Li C, Liu G, Liu S,
Xu Y, Di Y, Pan W and Li X: LncRNA CRNDE promotes the
epithelial-mesenchymal transition of hepatocellular carcinoma cells
via enhancing the Wnt/β-catenin signaling pathway. J Cell Biochem.
120:1156–1164. Nov 14–2018. View Article : Google Scholar : PubMed/NCBI
|
